Life science industry boosting local investment to avert supply chain risk: Willis
  • X
  • LinkedIn
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Life science industry boosting local investment to avert supply chain risk: Willis

Warehouse interior at sunset medicine getty.jpg

Risk managers in the life science industry are focusing on opportunities for local investment because of supply chain concerns raised by the Covid-19 pandemic, according to Willis Towers Watson.

According to the broker, companies in the sector are boosting regional production resources to mitigate the risks associated with relying on a single region for supply.

Pharmaceutical

Request a free trial:

Uncover exclusive insights tailored for insurance leaders

    • Stay Informed: Access exclusive industry insights
    • Gain a competitive advantage: Hear first about tactical developments
    • Make better decisions: Understand market dynamics in crucial lines of business
Gift this article